Vital Chemtech Limited (VITAL)
₹51.62 +0.17% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Vital Chemtech's revenue was ₹51.2 Cr (+51.5% year on year, +45.7% on the previous quarter), and net profit ₹2.6 Cr (+164.2% year on year); the operating margin was 11.9%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹51.2 | +51.5% | +45.7% |
| Operating profit | ₹6.1 | +140.8% | +53.1% |
| Net profit | ₹2.6 | +164.2% | +208.3% |
| EPS (₹) | 1.08 | +163.4% | +208.6% |
| Operating margin | 11.9% | — | — |
VITAL delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 91.89% of the VITAL shares traded on NSE were taken to delivery, against the stock's own 20-session average of 92.68%. That is close to its usual level. Turnover was under ₹1 lakh, so a handful of trades can move this figure. Volume was under a tenth of its average. It closed at a price band (circuit) on 2 sessions in about the last 20.
Delivery in the last 5 sessions: 62.6% · 71.2% · 76.4% · 95.6% · 91.9%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Vital Chemtech Limited reported the voting results of its 5th Annual General Meeting held on September 28, 2026. All 7 resolutions were approved unanimously with 100% of votes cast in favour, representing 74.88% total voter turnout (17,934,521 votes polled). Key resolutions included adopting FY26 financial statements, re-appointing Managing Director Vipul Bhatt and Whole-Time Director Jay Bhatt, approving material related party transactions with Vital Synthesis Limited, and ratifying M/s. SCS & Co. LLP as Secretarial Auditor for five years from FY26 to FY30.
- All 7 resolutions passed with 100.00% of polled votes in favour
- Overall voting turnout stood at 74.8797% (17,934,521 votes polled out of 23,951,100 total shares)
- Promoter group polled 100.00% of their 17,587,500 shares in favor of general resolutions
- Material Related Party Transactions approved with Vital Synthesis Limited for FY 2026-27 with 347,021 public votes cast in favour
- M/s. SCS and CO. LLP appointed as Secretarial Auditor for a 5-year term from FY 2025-26 to FY 2029-30
Vital Chemtech Limited reported the voting results of its 5th Annual General Meeting held on September 28, 2026. All 7 resolutions were approved unanimously with 100% of votes cast in favour, representing 74.88% total voter turnout (17,934,521 votes polled). Key resolutions included adopting FY26 financial statements, re-appointing Managing Director Vipul Bhatt and Whole-Time Director Jay Bhatt, approving material related party transactions with Vital Synthesis Limited, and ratifying M/s. SCS & Co. LLP as Secretarial Auditor for five years from FY26 to FY30.
- All 7 resolutions passed with 100.00% of polled votes in favour
- Overall voting turnout stood at 74.8797% (17,934,521 votes polled out of 23,951,100 total shares)
- Promoter group polled 100.00% of their 17,587,500 shares in favor of general resolutions
- Material Related Party Transactions approved with Vital Synthesis Limited for FY 2026-27 with 347,021 public votes cast in favour
- M/s. SCS and CO. LLP appointed as Secretarial Auditor for a 5-year term from FY 2025-26 to FY 2029-30
Vital Chemtech Limited reported the voting results of its 5th Annual General Meeting held on September 28, 2026. All 7 resolutions were approved unanimously with 100% of votes cast in favour, representing 74.88% total voter turnout (17,934,521 votes polled). Key resolutions included adopting FY26 financial statements, re-appointing Managing Director Vipul Bhatt and Whole-Time Director Jay Bhatt, approving material related party transactions with Vital Synthesis Limited, and ratifying M/s. SCS & Co. LLP as Secretarial Auditor for five years from FY26 to FY30.
- All 7 resolutions passed with 100.00% of polled votes in favour
- Overall voting turnout stood at 74.8797% (17,934,521 votes polled out of 23,951,100 total shares)
- Promoter group polled 100.00% of their 17,587,500 shares in favor of general resolutions
- Material Related Party Transactions approved with Vital Synthesis Limited for FY 2026-27 with 347,021 public votes cast in favour
- M/s. SCS and CO. LLP appointed as Secretarial Auditor for a 5-year term from FY 2025-26 to FY 2029-30
Vital Chemtech Limited has released the intimation and web-link for its Integrated Annual Report for FY 2025-26 under Regulation 36(1)(b) of SEBI LODR. The company's Annual General Meeting (AGM) is scheduled for September 28, 2026, via Video Conferencing. The cut-off date to determine e-voting eligibility has been set for September 21, 2026. Remote e-voting will begin on September 25, 2026, and conclude on September 27, 2026.
- AGM scheduled for Monday, September 28, 2026, at 12:00 noon IST via Video Conferencing
- Cut-off date for e-voting eligibility set to Monday, September 21, 2026
- Remote e-voting window opens September 25, 2026 (9:00 AM) and closes September 27, 2026 (5:00 PM)
- Dispatched Annual Report web-link to shareholders without registered email addresses
Vital Chemtech Limited has issued the notice for its 5th Annual General Meeting scheduled for September 28, 2026, via video conferencing, with September 21, 2026, as the cut-off date for e-voting. Key agenda items include the approval of material Related Party Transactions with subsidiary Vital Synthesis Limited for up to ₹85 Crore in FY 2026-27 (~57% of TTM revenue of ₹148 Crore). Additionally, the company is seeking approval for the 5-year re-appointments of Chairman & MD Vipul Bhatt and Whole-Time Director Jay Bhatt starting September 28, 2026.
- 5th Annual General Meeting scheduled for September 28, 2026, via VC/OAVM.
- Cut-off date for e-voting fixed as Monday, September 21, 2026.
- Shareholder approval sought for Related Party Transactions with Vital Synthesis Limited up to ₹85 Crore for FY 2026-27.
- Re-appointment proposed for MD Vipul Bhatt and Whole-Time Director Jay Bhatt for a 5-year term until September 27, 2031.
Vital Chemtech's Board of Directors has approved the re-appointment of promoter Mr. Vipul Bhatt as Chairman & Managing Director for a 5-year term from September 28, 2026 to September 27, 2031, subject to shareholder approval. The Board also approved the re-appointment of Mr. Jay Bhatt as Whole-Time Director for an identical 5-year tenure. The company has scheduled its 5th Annual General Meeting (AGM) on September 28, 2026, via video conferencing. Additionally, the Draft Directors' Report for FY26 was approved, and NSDL was designated as the e-voting agency.
- Re-appointment of Mr. Vipul Bhatt as Chairman & MD for a 5-year term (Sep 28, 2026 to Sep 27, 2031)
- Re-appointment of Mr. Jay Bhatt as Whole-Time Director for a 5-year term (Sep 28, 2026 to Sep 27, 2031)
- 5th Annual General Meeting convened for Monday, September 28, 2026 at 12:00 Noon IST
- Board meeting conducted on August 31, 2026 from 4:00 PM to 4:40 PM IST
Vital Chemtech Limited announced the appointment of Mr. Jitendra Raval as Chief Financial Officer with effect from August 15, 2026, succeeding Mr. Vipul Bhatt, who stepped down as CFO to focus on his role as Chairman and Managing Director. Mr. Raval brings 25 years of finance experience, including 15 years in the chemical industry with firms like Meghmani Group. Additionally, the Board reviewed and recorded a minor fine of ₹11,800 levied by NSE for a one-day technical delay in intimating a prior board meeting due to an exchange holiday.
- Appointed Mr. Jitendra Raval as CFO effective August 15, 2026, bringing 25 years of overall finance experience
- Mr. Vipul Bhatt resigned as CFO effective August 14, 2026, while continuing as Chairman and Managing Director
- NSE imposed a fine of ₹11,800 (inclusive of GST) under Regulation 29(2) for a 1-day intimation delay attributed to an exchange holiday
- Company completed migration from NSE Emerge to the NSE Main Board effective March 11, 2026
Vital Chemtech has separated its executive leadership functions as Chairman and Managing Director Vipul Bhatt stepped down from the additional role of Chief Financial Officer effective August 14, 2026. The company appointed Mr. Jitendra Raval as the new CFO effective August 15, 2026, who brings 25 years of finance experience including 15 years in the chemical sector. Alongside the leadership transition, the Board approved Q1 FY27 results reporting consolidated basic EPS of Rs 1.08 (vs Rs 0.36 in Q4 FY26). The Board also acknowledged a minor procedural fine of Rs 11,800 levied by NSE for a one-day delay in meeting intimation.
- Vipul Bhatt resigned as CFO effective August 14, 2026, while continuing as Chairman & Managing Director.
- Jitendra Raval appointed as Chief Financial Officer effective August 15, 2026, with 25 years of overall finance experience and 15 years in the chemical sector.
- Consolidated Basic EPS for the quarter ended June 30, 2026 stood at Rs 1.08 per share compared to Rs 0.36 in the prior quarter.
- NSE imposed a fine of Rs 11,800 (inclusive of GST) regarding a technical 1-day delay in board meeting intimation caused by an exchange holiday.
Vital Chemtech Limited has appointed Mr. Jitendra Raval as Chief Financial Officer effective August 15, 2026. Mr. Vipul Bhatt has resigned as CFO effective August 14, 2026, to facilitate the transition to professional management, while continuing as Chairman and Managing Director. Mr. Raval brings 25 years of overall finance experience, including 15 years in the chemical manufacturing industry. Additionally, the Board noted a minor technical fine of ₹11,800 imposed by the NSE for a 1-day delay in board meeting intimation.
- Appointed Chartered Accountant Jitendra Raval as CFO effective August 15, 2026.
- Mr. Raval brings 25 years of experience in finance and accounts, with 15 years in the chemical sector.
- Promoter Vipul Bhatt stepped down from the CFO role to separate executive duties but continues as CMD.
- Board recorded payment of ₹11,800 fine levied by NSE due to an inadvertent 1-day delay in meeting intimation.
- Reported basic/diluted EPS of ₹1.08 for the quarter ended June 30, 2026.
Vital Chemtech announced the appointment of Jitendra Raval as Chief Financial Officer effective August 15, 2026, bringing 25 years of finance experience, including 15 years in the chemical industry. Vipul Bhatt stepped down from the CFO role to separate executive functions while continuing as Chairman and Managing Director. The Board also approved unaudited Q1 FY27 results (reporting consolidated Basic EPS of ₹1.08) and addressed a nominal ₹11,800 fine levied by NSE for a technical one-day board meeting intimation delay.
- Appointed Chartered Accountant Jitendra Raval as CFO effective August 15, 2026, with 25 years of financial management experience
- CMD Vipul Bhatt relinquished the CFO post on August 14, 2026, separating management and finance responsibilities
- Reported consolidated Basic EPS of ₹1.08 for the quarter ended June 30, 2026
- Board addressed and noted payment of ₹11,800 technical penalty imposed by NSE for a 1-day delay in meeting intimation
Vital Chemtech Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the period ended June 30, 2026. The certificate, issued by its Registrar and Share Transfer Agent (RTA), Skyline Financial Services Private Limited, confirms that share certificates received for dematerialization were processed and the depositories' names were updated in the company's records. This is a standard administrative filing required of all listed companies to ensure the integrity of electronic shareholding records. The company maintains a healthy promoter holding of 73.43% and a low debt-to-equity ratio of 0.10.
- Quarterly compliance certificate submitted for the period ended June 30, 2026
- Registrar and Share Transfer Agent (RTA) confirmed as Skyline Financial Services Private Limited
- Filing submitted to the National Stock Exchange (NSE) on July 4, 2026
- Company maintains a net worth of Rs 113 Cr as per latest financial context
Vital Chemtech Limited has officially notified the exchange regarding the closure of its trading window starting July 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the announcement of Q1 financial results for the period ending June 30, 2026. The window will remain closed for all designated persons and insiders until 48 hours after the results are declared. This is a standard regulatory procedure and does not indicate any fundamental change in the company's operations.
- Trading window closure commences on Wednesday, July 1, 2026.
- Closure pertains to the declaration of Unaudited Standalone & Consolidated Financial Results for Q1 FY27.
- The restriction will be lifted 48 hours after the financial results are officially announced.
- Applies to all Promoters, Directors, Key Managerial Personnel, and Designated Employees.
Vital Chemtech Limited has re-submitted its audited financial results for the year ended March 31, 2026, following an observation from the NSE regarding the filing format. The results, originally approved on May 29, 2026, carry an unmodified audit opinion from statutory auditors M/s. Abhishek Kumar & Associates. Additionally, the board has appointed M/s R J & Associates as the Cost Auditor for the financial year 2026-27 to ensure compliance with cost accounting standards.
- Re-submission of FY26 financial results in machine-readable and searchable format as per NSE observation dated June 12, 2026.
- Board confirmed audited standalone and consolidated financial results for the year ended March 31, 2026, with an unmodified opinion.
- Appointment of M/s R J & Associates, Cost Accountants, as Cost Auditor for the Financial Year 2026-27.
- The company has committed to implementing measures for timely and accurate future filings in the required formats.
- Statutory audit for the period was conducted by M/s. Abhishek Kumar & Associates, Chartered Accountants.
Vital Chemtech's subsidiary, Vital Synthesis Limited, has secured a final Consolidated Consent and Authorization (CCA) from the Gujarat Pollution Control Board (GPCB). This regulatory milestone provides long-term operational visibility as the approval is valid until March 26, 2031. The consent allows the subsidiary to proceed with manufacturing advanced intermediates and custom synthesis, effectively reducing compliance risks and supporting the group's overall expansion strategy in the specialty chemicals market.
- Subsidiary Vital Synthesis Limited received final CCA approval from Gujarat Pollution Control Board.
- The regulatory approval is valid for a long-term period ending March 26, 2031.
- Enables manufacturing operations for advanced intermediates and custom synthesis projects.
- Strengthens the company's ESG and governance profile by ensuring environmental compliance.
- Provides multi-year operational visibility for the subsidiary's growth and expansion plans.
Vital Chemtech's subsidiary, Vital Synthesis Limited, has received the Final Consent Order (CC&A) from the Gujarat Pollution Control Board (GPCB). This regulatory approval allows the subsidiary to manufacture products under the Water, Air, and Environment Protection Acts. The authorization is valid for a long-term period until March 26, 2031, ensuring operational stability and legal compliance for the subsidiary's manufacturing activities.
- Subsidiary Vital Synthesis Limited received Consolidated Consent and Authorization (CC&A) via CCA No. AWH-157796.
- The regulatory approval from GPCB is valid for nearly five years, expiring on March 26, 2031.
- The consent covers compliance under the Water Act-1974, Air Act-1981, and Hazardous Waste Rules-2016.
- This clearance is a critical milestone for the subsidiary to commence or continue manufacturing operations legally.
Financial Performance
Revenue Growth by Segment
Not disclosed in available documents. The provided financial statements focus on the Balance Sheet as of September 30, 2025, rather than segmented revenue growth.
Profitability Margins
Not disclosed in available documents. Profit and loss figures for the half-year ended September 30, 2025, were not included in the provided text fragments.
Capital Expenditure
As of September 30, 2025, the company reported total assets of INR 129.14 Cr (12,913.51 Lakhs), a 1.5% increase from INR 127.23 Cr (12,722.92 Lakhs) on March 31, 2025. Specific planned CapEx figures are not disclosed.
Credit Rating & Borrowing
The company has reduced its long-term borrowings by 40.8%, from INR 1.20 Cr (120.05 Lakhs) in March 2025 to INR 0.71 Cr (71.11 Lakhs) in September 2025. Short-term borrowings also decreased by 5.2% to INR 11.21 Cr (1,121.38 Lakhs). Specific credit ratings and interest rates are not disclosed.
Operational Drivers
Raw Materials
Not disclosed in available documents. However, the company operates in the chemical sector with a subsidiary named Vital Alkoxides Private Limited, implying the use of alcohols and alkali metals as primary inputs.
Strategic Growth
Growth Strategy
The company is pursuing a major strategic transition by migrating its securities from the NSE Emerge (SME) platform to the Main Boards of both the National Stock Exchange (NSE) and BSE Limited. This move is intended to enhance liquidity, attract institutional investors, and improve the company's valuation profile. Growth is also supported by its subsidiaries, Vital Synthesis Limited and Vital Alkoxides Private Limited, which focus on specialized chemical manufacturing.
Products & Services
Chemical products, specifically alkoxides (via Vital Alkoxides Private Limited) and other synthesized chemical compounds.
Brand Portfolio
Vital Chemtech
Market Expansion
The company is expanding its capital market presence by moving from the SME platform to the Main Boards of NSE and BSE as of November 2025.
Strategic Alliances
The company operates through subsidiaries: Vital Synthesis Limited and Vital Alkoxides Private Limited.
External Factors
Industry Trends
The Indian specialty chemical industry is currently seeing a shift toward domestic manufacturing and import substitution. Vital Chemtech's positioning in alkoxides and synthesis aligns with this trend, as these are critical intermediates for various industrial applications.
Competitive Landscape
The company operates in the competitive chemical manufacturing sector, transitioning from an SME-scale player to a Main Board-listed entity.
Competitive Moat
The company's moat is currently limited by its SME status, but the migration to the Main Board and its specialized focus on alkoxides provide a platform for scaling. Its low debt-to-equity ratio (approx 0.13 based on INR 11.92 Cr debt vs INR 93.98 Cr equity) provides a sustainable financial cushion for expansion.
Regulatory & Governance
Industry Regulations
The company is currently exempt from certain Corporate Governance requirements (Regulation 27(2) of SEBI LODR) because it is listed on the SME Exchange and has a paid-up capital below INR 10 Cr and net worth below INR 25 Cr (as of the previous financial year criteria). However, this will change upon migration to the Main Board.
Taxation Policy Impact
The company reports Deferred Tax Liabilities of INR 0.59 Cr (58.88 Lakhs) as of September 30, 2025.
Risk Analysis
Key Uncertainties
The primary uncertainty is the successful execution of the migration to the Main Board and the subsequent requirement to meet higher governance and disclosure standards.
Credit & Counterparty Risk
Trade payables increased significantly by 149% from INR 1.03 Cr (102.81 Lakhs) in March 2025 to INR 2.56 Cr (255.99 Lakhs) in September 2025, indicating a change in working capital management or supplier terms.
